Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein–Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab
Titel:
Determinants of Plaque Progression Despite Very Low Low-Density Lipoprotein–Cholesterol Levels With the PCSK9 Inhibitor, Evolocumab
Auteur:
Honda, Satoshi Puri, Rishi Anderson, Todd Kastelein, John J.P. Brennan, Danielle M. Kassahun, Helina Somaratne, Ransi Wasserman, Scott M. Nissen, Steve E. Nicholls, Stephen J.